Jill Newman to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Jill Newman has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.048
-
Program to Avoid Cerebrovascular Events through Systematic Electronic Tracking and Tailoring of an Eminent Risk factor: Protocol of a RCT. J Stroke Cerebrovasc Dis. 2021 Aug; 30(8):105815.
Score: 0.048